Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-02
DOI
10.1038/s41467-020-15461-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Whole‐exome sequencing of ovarian cancer families uncovers putative predisposition genes
- (2019) Qianqian Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Pathogenic Germline Variants in 10,389 Adult Cancers
- (2018) Kuan-lin Huang et al. CELL
- Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility
- (2018) Simone M. Rowley et al. GENETICS IN MEDICINE
- The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function
- (2018) Anbarasu Kumaraswamy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing
- (2018) Hsiao-Mei Lu et al. JAMA Oncology
- Germline pathogenic variants identified in women with ovarian tumors
- (2018) Natalie J. Carter et al. GYNECOLOGIC ONCOLOGY
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients
- (2018) Magdalena Koczkowska et al. Cancers
- Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction
- (2017) Michelle R. Jones et al. GYNECOLOGIC ONCOLOGY
- Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls
- (2017) Jenna Lilyquist et al. GYNECOLOGIC ONCOLOGY
- Inhibition of Proteasome Activity Induces Aggregation of IFIT2 in the Centrosome and Enhances IFIT2-Induced Cell Apoptosis
- (2017) Limin Chen et al. International Journal of Biological Sciences
- Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability
- (2017) Jaime L. Stafford et al. PLoS One
- Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene
- (2017) Ed Dicks et al. Oncotarget
- Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer
- (2017) Akira Hirasawa et al. Oncotarget
- High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma
- (2017) Yi Xu et al. Scientific Reports
- Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)
- (2017) Philipp Harter et al. PLoS One
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Truncated RASSF7 promotes centrosomal defects and cell death
- (2016) Tulay Gulsen et al. DEVELOPMENTAL BIOLOGY
- Ovarian cancer in Lynch syndrome; a systematic review
- (2016) J.M. Helder-Woolderink et al. EUROPEAN JOURNAL OF CANCER
- Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
- (2016) Ella R. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence ofBRCA1/2germline mutations in 21 401 families with breast and ovarian cancer
- (2016) Karin Kast et al. JOURNAL OF MEDICAL GENETICS
- Analysis of protein-coding genetic variation in 60,706 humans
- (2016) Monkol Lek et al. NATURE
- Ensembl 2017
- (2016) Bronwen L. Aken et al. NUCLEIC ACIDS RESEARCH
- The Ensembl gene annotation system
- (2016) Bronwen L. Aken et al. Database-The Journal of Biological Databases and Curation
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population
- (2015) Honglin Song et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Germline RECQL mutations are associated with breast cancer susceptibility
- (2015) Cezary Cybulski et al. NATURE GENETICS
- Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome
- (2015) E Hedström et al. Cell Death & Disease
- Patterns and functional implications of rare germline variants across 12 cancer types
- (2015) Charles Lu et al. Nature Communications
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Second-generation PLINK: rising to the challenge of larger and richer datasets
- (2015) Christopher C Chang et al. GigaScience
- Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer
- (2014) L. Zhou et al. Clinical & Translational Oncology
- Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations
- (2014) Lise B. Ahlborn et al. Familial Cancer
- The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population
- (2014) H. Song et al. HUMAN MOLECULAR GENETICS
- Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer
- (2014) Jun Zou et al. MEDICAL ONCOLOGY
- Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications
- (2014) Andy Rimmer et al. NATURE GENETICS
- Breast-Cancer Risk in Families with Mutations in PALB2
- (2014) Antonis C. Antoniou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated analysis of germline and somatic variants in ovarian cancer
- (2014) Krishna L. Kanchi et al. Nature Communications
- Risk of benign tumours of nervous system and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study
- (2012) O O Seminog et al. BRITISH JOURNAL OF CANCER
- Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
- (2012) M.-H. Tan et al. CLINICAL CANCER RESEARCH
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles
- (2012) Ella R. Thompson et al. PLoS Genetics
- Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
- (2011) S. Casadei et al. CANCER RESEARCH
- Wrap53, a novel regulator of p53
- (2011) Marianne Farnebo CELL CYCLE
- RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the activity of phosphorylated-MKK7
- (2011) S Takahashi et al. CELL DEATH AND DIFFERENTIATION
- Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors
- (2011) Zohreh Ketabi et al. GYNECOLOGIC ONCOLOGY
- Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
- (2011) Ella R. Thompson et al. HUMAN MUTATION
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
- Germline mutations in RAD51D confer susceptibility to ovarian cancer
- (2011) Chey Loveday et al. NATURE GENETICS
- Mutations in BRIP1 confer high risk of ovarian cancer
- (2011) Thorunn Rafnar et al. NATURE GENETICS
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A screen for deubiquitinating enzymes involved in the G2/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stability
- (2010) Bernadette Aressy et al. CELL CYCLE
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- Cancer predisposing missense and protein truncatingBARD1mutations in non-BRCA1orBRCA2breast cancer families
- (2010) Sylvia De Brakeleer et al. HUMAN MUTATION
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Mutation of the RAD51C gene in a Fanconi anemia–like disorder
- (2010) Fiona Vaz et al. NATURE GENETICS
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
- (2010) Alfons Meindl et al. NATURE GENETICS
- Wrap53, a Natural p53 Antisense Transcript Required for p53 Induction upon DNA Damage
- (2009) Salah Mahmoudi et al. MOLECULAR CELL
- Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, Mirror image polydactyly 1, in nasopharyngeal carcinoma
- (2009) A. K. L. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started